COVID-19 vaccine: Pfizer to seek FDA authorization late November - Business Insider

Pfizer expected to know whether the vaccine is effective by the end of October, it said. However, FDA rules require companies to provide two months of safety data following the final dose of a vaccine. This data would only be ready in late November, it said. "To ensure public trust and clear up a great deal of confusion, I believe it is essential for the public to understand our estimated timelines," Pfizer's CEO Albert Bourla said.

Effectiveness trials monitor whether it protects the majority of vaccinated people from COVID-19. These results could be available by the end of October, Pfizer said, when it would be reviewed by independent scientists. Approval of the drug's safety is dependent on the company monitoring data from thousands of patients for two months after they receive the final vaccine. This data should be available by the third week of November, it said.

Great news for Pfizer,and hopefully for all of us

Great news! 👏👍🙏

wow

Россия Последние новости, Россия Последние новости

Similar News:Вы также можете прочитать подобные новости, которые мы собрали из других источников новостей

Inside a Amazon arbitrageurs group where members sell $100K in goods - Business InsiderPeople are quitting their jobs to make thousands selling everyday items on Amazon. Here's a look inside one exclusive resale group, where members have sold over $400,000 worth of good since May.
Источник: BusinessInsider - 🏆 729. / 51 Прочитайте больше »

5 things to know before the stock market opens FridayU.S. stock futures rose Friday, with Pfizer up after saying it could apply for FDA emergency use authorization for its Covid-19 vaccine candidate in late November. thanks With all that Trump said in the town hall..why is media focused on covid test and QAnon? These segments last 1/100 of the program and he talked about TONS more stuff This should be gate that john must open JohnVuliGate
Источник: CNBC - 🏆 12. / 72 Прочитайте больше »